This was largely due to the large and clunky device. In June 2014, the US Food and Drug Administration (FDA) approved a new formulation of inhaled insulin (Afrezza- inhalation powder). This is based ...

Cipla has launched India's first inhalable insulin, Afrezza, after receiving approval from the Central Drugs Standard Control Organisation (CDSCO). Afrezza, developed by MannKind Corporation in ...

When you have diabetes, insulin is vital to help keep your blood sugar levels in check. If you have type 1 diabetes, you must inject insulin daily. Those with type 2 diabetes may also require ...

Industry experts expect that the Central Drugs Standard Control Organisation (CDSCO) could reclassify more medical devices based on their risk approach under the Medical Device Rules (MDR), 2017. This ...

Diabetes mellitus is a metabolic disease that causes high blood sugar. Your body either doesn’t make enough insulin or can’t effectively use the insulin it makes. The hormone insulin moves ...

Polycystic ovary syndrome (PCOS) can put you at risk for insulin resistance. Watch for symptoms of insulin resistance that are common for females with PCOS. These include cravings and frequent ...

Cipla's (BOM: 500087) launch of Afrezza, India's first inhalable insulin, is another case in point. Cipla launched India's first inhalable insulin after receiving approval from the Central Drugs ...

After months of silence, we finally know that the Chainsaw Man movie is officially releasing in 2025. That's right, instead of a second season (for now, anyway), Denji's story continues in a ...

While this option may be less expensive and seems convenient, it’s best to consult a doctor about dosage if you use it, says Joshua J. Neumiller, CDCES, PharmD, the president elect of ...